Johnson Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Sell |
463
-23
| -5% | -$12.1K | ﹤0.01% | 715 |
|
|
2025
Q1 | $308K | Sell |
486
-1
| -0.2% | -$635 | ﹤0.01% | 631 |
|
|
2024
Q4 | $347K | Buy |
487
+207
| +74% | +$147K | ﹤0.01% | 611 |
|
|
2024
Q3 | $294K | Buy |
280
+55
| +24% | +$57.7K | ﹤0.01% | 645 |
|
|
2024
Q2 | $236K | Hold |
225
| – | – | ﹤0.01% | 665 |
|
|
2024
Q1 | $217K | Buy |
+225
| New | +$217K | ﹤0.01% | 696 |
|
|
2023
Q4 | – | Sell |
-340
| Closed | -$280K | – | 731 |
|
|
2023
Q3 | $280K | Sell |
340
-740
| -69% | -$609K | ﹤0.01% | 574 |
|
|
2023
Q2 | $776K | Sell |
1,080
-10
| -0.9% | -$7.19K | 0.01% | 396 |
|
|
2023
Q1 | $896K | Buy |
1,090
+15
| +1% | +$12.3K | 0.01% | 368 |
|
|
2022
Q4 | $776K | Sell |
1,075
-96
| -8% | -$69.3K | 0.01% | 382 |
|
|
2022
Q3 | $807K | Buy |
1,171
+24
| +2% | +$16.5K | 0.01% | 361 |
|
|
2022
Q2 | $678K | Buy |
1,147
+79
| +7% | +$46.7K | 0.01% | 391 |
|
|
2022
Q1 | $746K | Buy |
1,068
+47
| +5% | +$32.8K | 0.01% | 398 |
|
|
2021
Q4 | $645K | Sell |
1,021
-5
| -0.5% | -$3.16K | 0.01% | 409 |
|
|
2021
Q3 | $621K | Buy |
1,026
+19
| +2% | +$11.5K | 0.01% | 404 |
|
|
2021
Q2 | $562K | Buy |
1,007
+4
| +0.4% | +$2.23K | 0.01% | 418 |
|
|
2021
Q1 | $475K | Buy |
1,003
+30
| +3% | +$14.2K | 0.01% | 433 |
|
|
2020
Q4 | $470K | Buy |
973
+3
| +0.3% | +$1.45K | 0.01% | 409 |
|
|
2020
Q3 | $543K | Hold |
970
| – | – | 0.01% | 374 |
|
|
2020
Q2 | $605K | Sell |
970
-250
| -20% | -$156K | 0.01% | 361 |
|
|
2020
Q1 | $596K | Sell |
1,220
-24
| -2% | -$11.7K | 0.01% | 334 |
|
|
2019
Q4 | $467K | Sell |
1,244
-78
| -6% | -$29.3K | 0.01% | 428 |
|
|
2019
Q3 | $367K | Sell |
1,322
-60
| -4% | -$16.7K | 0.01% | 464 |
|
|
2019
Q2 | $432K | Buy |
1,382
+547
| +66% | +$171K | 0.01% | 449 |
|
|
2019
Q1 | $342K | Buy |
+835
| New | +$342K | 0.01% | 478 |
|